ELOXATIN

This brand name is authorized in Brazil, Ecuador, Estonia, Hong Kong, Ireland, Mexico, Singapore, South Africa

Active ingredients

The drug ELOXATIN contains one active pharmaceutical ingredient (API):

1 Oxaliplatin UNII 04ZR38536J - OXALIPLATIN

Oxaliplatin is an antineoplastic active substance belonging to a new class of platinum-based compounds in which the platinum atom is complexed with 1,2-diaminocyclohexane (“DACH”) and an oxalate group. Read about Oxaliplatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XA03	Oxaliplatin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XA Platinum compounds
Discover more medicines within L01XA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720080082817, 576720080082917
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H3310213
Country: EE	Ravimiamet	Identifier(s): 1244168, 1244179, 1244180
Country: HK	Department of Health Drug Office	Identifier(s): 55336
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 475M98
Country: SG	Health Sciences Authority	Identifier(s): 13237P
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/26/0497, A39/26/0498, A39/26/0499